WAGNER CHARLES F JR (CIK 1223348) reported 19 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-26). Recent activity: Sell VRTX (1,744 shares), Buy VRTX (7,365 shares), Sell VRTX (2,294 shares), Sell VRTX (4,565 shares), Sell VRTX (3,045 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Sell | 1,744 | $846,032 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Buy | 7,365 | $0 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Sell | 2,294 | $1.1M |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Sell | 4,565 | $2.2M |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Sell | 3,045 | $1.4M |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Buy | 9,440 | $0 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Buy | 4,160 | $0 |
| 2026-01-08 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Buy | 9,532 | $1.8M |
| 2026-01-08 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Sell | 9,532 | $4.4M |
| 2025-12-05 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Sell | 7,000 | $3.2M |
| 2025-12-05 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | Sell | 7,000 | $3.2M |
| 2025-03-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP & Chief Financial Officer | Sell | 3,298 | $1.6M |
| 2025-02-28 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP & Chief Financial Officer | Sell | 4,962 | $2.4M |
| 2025-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP & Chief Financial Officer | Sell | 3,310 | $1.6M |
| 2025-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP & Chief Financial Officer | Sell | 2,293 | $1.1M |
| 2025-02-14 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP & Chief Financial Officer | Buy | 6,655 | $0 |
| 2025-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP & Chief Financial Officer | Sell | 2,649 | $1.2M |
| 2025-02-06 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP & Chief Financial Officer | Buy | 10,262 | $0 |
| 2025-02-06 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP & Chief Financial Officer | Buy | 7,114 | $0 |
Source: SEC Form 4 filings · as of 2026-02-26